BioNotebook: Aerie, Dynavax, Tetraphase, MEI Pharma, Sorrento, Can-Fite

 
• By Mandy Jackson

Aerie prices $67.2m IPO; Dynavax sells $132.2m in stock, debt; Tetraphase plans $40m offering; MEI prices $35m offering; Sorrento joins Nasdaq, raises $30m; and Can-Fite garners $6m in Tel Aviv.

More from Anticancer

More from Therapy Areas